Report Overview

The US Dry Eye Syndrome Treatment market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Dry Eye Syndrome or keratoconjunctivitis sicca is referred to inappropriate formation of tears that evaporates too quickly or dearth of tears that creates problem in lubrication and nourishment of the eye. This condition can lead to several disorders such as cornea, ulcers and loss of vision



Market Drivers

The Dry Eye Syndrome Treatment market is anticipated to grow in the forecast, owing to the factors such as growing prevalence of dry eye syndrome, increasing geriatric population, growing awareness about diagnosis and treatment of the diseases and rise in use of contact lenses

According to American Association of Ophthalmology (AAO), approximately 20 million people in the United States (344 million people worldwide) have dry eye disease (DED), and that number is growing in both young and old adults, making it imperative that clinicians figure out how best to treat it

The presence of a wide range of treatment options available such as lubricant eye drops, punctual bags, artificial tears, and drugs for dry eye syndrome is expected to add fuel to the market